Farnesoid x receptor (FXR), deficiency of which mediates diabetes acceleration of nephropathy in T1DM, inhibits SREBP-2 and elevates miR-29a, thus relieving renal fibrosis. The gene discussed is NR1H4; the disease is kidney disorder.